MICHAEL M WARD, MD
Osteopathic Medicine at Marshall Way, Swansboro Country, CA
License number
California A123523
Category
Osteopathic Medicine
Type
Hospitalist
Address
Address
2
1100 Marshall Way, Swansboro Country, CA 95667
PO Box 45680, San Francisco, CA 94145
PO Box 45680, San Francisco, CA 94145
Phone
(530) 622-1441
Personal information
See more information about MICHAEL M WARD at radaris.comName
Address
Phone
500 N State College Blvd Ste 1, Orange, CA 92868
4 Sandpiper Ct, San Rafael, CA 94903
5039 Alicante Way, Oceanside, CA 92056
4881 Ruth Ave, Los Angeles, CA 90041
48623 Paseo Tarazo, La Quinta, CA 92253
Professional information
Michael Ward - San Francisco, CA
Work:
Handy Man, Maintenance and Repair Workers, General
Event Planner Handy Man, Maintenance and Repair Workers, General Handy Man, Maintenance and Repair Workers, General - San Francisco, CA
Maintenance Supervisor
Event Planner Handy Man, Maintenance and Repair Workers, General Handy Man, Maintenance and Repair Workers, General - San Francisco, CA
Maintenance Supervisor
Trichoderma Promoter
US Patent:
8044192, Oct 25, 2011
Filed:
Aug 18, 2008
Appl. No.:
12/193614
Inventors:
Michael Ward - San Francisco CA, US
Assignee:
Danisco US Inc. - Palo Alto CA
International Classification:
C07H 21/04, C12N 15/63, C12N 1/15, C12P 21/00
US Classification:
536 241, 4353201, 43525411, 435 711
Abstract:
A promoter for use in producing proteins in filamentous fungal host cells is provided. In one embodiment, the promoter comprises SEQ ID NO:1, or a variant or a truncated form thereof that has promoter activity in a host cell. Also provided are recombinant nucleic acids, vectors containing the promoter and host cells containing a recombinant nucleic acid or vector. Methods of producing a protein using the host cells are also provided.
Michael Ward
Location:
San Francisco Bay Area
Industry:
Information Technology and Services
Method Of Increasing Recovery Of Heterologous Active Enzymes Produced In Plants
US Patent:
6632930, Oct 14, 2003
Filed:
Jun 14, 2001
Appl. No.:
09/881165
Inventors:
Elizabeth Hood - College Station TX
John A. Howard - College Station TX
Michele Bailey - College Station TX
Franciscus J. C. van Gastel - Union City CA
Michael Ward - San Francisco CA
Huaming Wang - Fremont CA
Susan Woodard - College Station TX
John A. Howard - College Station TX
Michele Bailey - College Station TX
Franciscus J. C. van Gastel - Union City CA
Michael Ward - San Francisco CA
Huaming Wang - Fremont CA
Susan Woodard - College Station TX
Assignee:
Prodigene, Inc. - College Station TX
Genencor International Inc. - Palo Alto CA
Genencor International Inc. - Palo Alto CA
International Classification:
A23J 100
US Classification:
530412, 435 18, 435 25, 435189, 435195, 536 232, 800278
Abstract:
A method of increasing recovery of active enzyme produced in a plant is provided where the enzyme requires a transitional metal cofactor for activation. The metal cofactor is supplied to the enzyme during plant development, during extraction, or after extraction. Recovery of active enzyme is also provided by incubating the extracted enzyme at a non-enzyme degrading temperature. Addition of a negative ion salt further improves active enzyme recovery. Optimum salt concentrations for recovery of laccase from plants using copper solutions is provided.
Filamentous Fungi Having An Altered Viscosity Phenotype
US Patent:
2013022, Aug 29, 2013
Filed:
Aug 25, 2011
Appl. No.:
13/817421
Inventors:
Timothy C. Dodge - Sunnyvale CA, US
Aleksandra Virag - Cupertino CA, US
Michael Ward - San Francisco CA, US
Aleksandra Virag - Cupertino CA, US
Michael Ward - San Francisco CA, US
Assignee:
DANISCO US INC. - Palo Alto CA
International Classification:
C12N 15/80
US Classification:
435471, 4352546, 530350, 435183
Abstract:
Described are compositions and methods relating variant filamentous fungi having altered growth characteristics. Such variants are well-suited for growth in submerged cultures, e.g., for the large-scale production of enzymes and other proteins for commercial applications.
Bgl7 Beta-Glucosidase And Nucleic Acids Encoding The Same
US Patent:
2013017, Jul 11, 2013
Filed:
Dec 17, 2012
Appl. No.:
13/717115
Inventors:
DANISCO US INC. - Palo Alto CA, US
Michael Ward - San Francisco CA, US
Michael Ward - San Francisco CA, US
Assignee:
DANISCO US INC. - Palo Alto CA
International Classification:
C12N 9/42
US Classification:
435209
Abstract:
The present invention provides a novel β-glucosidase nucleic acid sequence, designated bgl7, and the corresponding BGL7 amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding BGL7, recombinant BGL7 proteins and methods for producing the same.
Bgl3 Beta-Glucosidase And Nucleic Acids Encoding The Same
US Patent:
7273742, Sep 25, 2007
Filed:
May 16, 2005
Appl. No.:
11/130427
Inventors:
Nigel Dunn-Coleman - Los Gatos CA, US
Frits Goedegebuur - Vlaardingen, NL
Michael Ward - San Francisco CA, US
Jian Yao - Sunnyvale CA, US
Frits Goedegebuur - Vlaardingen, NL
Michael Ward - San Francisco CA, US
Jian Yao - Sunnyvale CA, US
Assignee:
Genencor International, Inc. - Palo Alto CA
International Classification:
C12N 9/42, C12N 1/12, C12N 15/00, C12P 7/06
US Classification:
435209, 435 4, 435 6, 435 691, 435183, 4352523, 4353201, 435161, 536 232, 536 237, 536 2374, 510114, 510392, 510515
Abstract:
The present invention provides a novel β-glucosidase nucleic acid sequence, designated bgl3, and the corresponding BGL3 amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding BGL3, recombinant BGL3 proteins and methods for producing the same.
Production Of Functional Antibodies In Filamentous Fungi
US Patent:
2004001, Jan 29, 2004
Filed:
Apr 17, 2003
Appl. No.:
10/418836
Inventors:
Scott Power - San Bruno CA, US
Huaming Wang - Fremont CA, US
Michael Ward - San Francisco CA, US
Huaming Wang - Fremont CA, US
Michael Ward - San Francisco CA, US
International Classification:
G01N033/53, G01N033/569, C12N009/00, C07K016/14
US Classification:
435/007310, 530/388500, 435/188500
Abstract:
Described herein are methods for the production of monoclonal antibodies in filamentous fungi host cells. The monoclonal antibodies are expressed as full-length fusion proteins that retain functional antigen binding and antibody-dependent cellular cytotoxicity capabilities. Improvements in the cleavage of the glucoamylase-light chain fusion protein to yield a mature antibody are also provided. The antibodies produced in filamentous fungi show equivalent pharmacokinetic disposition to antibodies produced in mammalian cells.
Bgl3 Beta-Glucosidase And Nucleic Acids Encoding The Same
US Patent:
7960146, Jun 14, 2011
Filed:
Aug 17, 2007
Appl. No.:
11/893925
Inventors:
Nigel Dunn-Coleman - Los Gatos CA, US
Frits Goedegebuur - Vlaardingen, NL
Michael Ward - San Francisco CA, US
Jian Yao - Sunnyvale CA, US
Frits Goedegebuur - Vlaardingen, NL
Michael Ward - San Francisco CA, US
Jian Yao - Sunnyvale CA, US
Assignee:
Danisco US Inc. - Palo Alto CA
International Classification:
C12P 19/00, C12N 9/00, C12N 9/24, C12N 1/20, C12N 15/00
US Classification:
435 72, 435183, 435200, 4352523, 4353201, 536 232
Abstract:
The present invention provides a novel β-glucosidase nucleic acid sequence, designated bgl3, and the corresponding BGL3 amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding BGL3, recombinant BGL3 proteins and methods for producing the same.
Michael Ward
Location:
San Francisco Bay Area
Industry:
Online Media